We’ve just launched a new portal to help you explore stocks, crypto, ETFs, and more data

GUD

TSX
5.68000 CAD
0.39
6.43%
Last update May 8, 3:59 PM EDT
Market closed
Day range
5.5
6.040000
Previous close
6.070000
Open
6.040000
Access this stock data via API
Subscribe
Knight Therapeutics Inc.
5.68
0.39
6.43%

Overview

Description

Knight Therapeutics Inc. is a Canadian-based specialty pharmaceutical company. Its core purpose is to develop, acquire, license, and deliver innovative pharmaceutical products to fulfill unmet medical needs. The company places a strong emphasis on the therapeutic fields of oncology, infectious diseases, and select consumer health products. Utilizing strategic partnerships, in-licensing, and acquisitions, Knight Therapeutics bolsters its product portfolio with high-potential medications that meet rigorous regulatory standards. Operating largely across Canada and Latin America, it plays a crucial role in enhancing healthcare outcomes within these geographies. The company is noteworthy for its commitment to sustainable growth and value creation in the pharmaceutical industry, and its adaptability in responding to market demands and healthcare trends solidifies its standing as a key player in the regional pharmaceutical landscape.

About

CEO
Ms. Samira Sakhia BCom, CA, CPA, MBA
Employees
745
Address
3400 de Maisonneuve Blvd. W.
Suite 1055
Montreal, H3Z 3B8, QC
Canada
Phone
514-484-4483
Website
Instrument type
Common stock
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
Canada
MIC code
XTSE
Market closed

Exchange is currently closed
Pre-market opens in 1 minute

07:58
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
08:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 17:00
All times are displayed in the America/Toronto timezone (EDT, UTC-04:00).